Literature DB >> 7911792

Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity.

H Jaspers1, A Horvåth, I Mezö, G Kéri, G Van Binst.   

Abstract

A series of somatostatin analogues with varying activities have been studied by 1H NMR in CD3OH at low temperature in order to find a possible structural explanation for the differentiation of biological activities. In somatostatin analogues with GH release inhibitory activity a beta-turn/beta-sheet backbone conformation is present, which is shown to be characteristic of somatostatin-derived peptides exhibiting this biological activity. On the other hand, among the analogues with antitumor activity, a deviation from these typical structural features is clearly observed, but not general conformational model can be proposed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911792     DOI: 10.1111/j.1399-3011.1994.tb00390.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  6 in total

1.  A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

Authors:  G Kéri; J Erchegyi; A Horváth; I Mezõ; M Idei; T Vántus; A Balogh; Z Vadász; G Bökönyi; J Seprõdi; I Teplán; O Csuka; M Tejeda; D Gaál; Z Szegedi; B Szende; C Roze; H Kalthoff; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Anti-inflammatory effect of synthetic somatostatin analogues in the rat.

Authors:  Z Helyes; E Pintér; J Németh; G Kéri; M Thán; G Oroszi; A Horváth; J Szolcsányi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Judit Erchegyi; Steven C Koerber; Jean Claude Reubi; Jean Rivier; Roland Riek
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

4.  Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.

Authors:  Christy Rani R Grace; Judit Erchegyi; Jean Claude Reubi; Jean E Rivier; Roland Riek
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

5.  Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232.

Authors:  C C Diaconu; M Szathmári; G Kéri; A Venetianer
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

6.  Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.

Authors:  B Szende; A Horváth; G Bökönyi; G Kéri
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.